| A retrospective analysis of the ICOGEN clinical trial demonstrates the utility of VeriStrat to predict outcome in an all Chinese cohort treated with EGFR TKI. | |
| Shi, Yuankai; Han, Xiaohong; Zhang, Li; Ding, Lieming; Dupuis, Nicholas; Nickel, Alex; Feng, Lana; Pestano, Gary Anthony; Liu, Xiaoqing; Zhou, Caicun | |
| 2016 | |
| 会议名称 | JOURNAL OF CLINICAL ONCOLOGY |
| 会议日期 | 2016-05-20 |
| 收录类别 | CPCI-S |
| URL标识 | 查看原文 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6384888 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Shi, Yuankai,Han, Xiaohong,Zhang, Li,et al. A retrospective analysis of the ICOGEN clinical trial demonstrates the utility of VeriStrat to predict outcome in an all Chinese cohort treated with EGFR TKI.[C]. 见:JOURNAL OF CLINICAL ONCOLOGY. 2016-05-20. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论